Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04297969 · ClinicalTrials.gov registry record
Hyperopia Detection GCK With Glow Fixation
A clinical trial, sponsored by Alaska Blind Child Discovery.
- Completed
- Registry status
- 133
- Enrollment target
NCT04297969: Completed study, sponsored by Alaska Blind Child Discovery.
NCT04297969 is a clinical trial that has completed, run by Alaska Blind Child Discovery. The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04297969 has completed, sponsored by Alaska Blind Child Discovery.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
Study Summary
"GoCheck Kids" has added to its iPhone 7+ smart phone with flash concentrator a non-accommodating glow box fixation target. In pediatric eye patients, the "GCK" with glow box is compared to cycloplegic refraction as well as School Bus Accommodation-relaxing skiascopy, "2WIN" photoscreener and "Retinomax."
Primary Outcome
presence of refractive risk factors (anisometropia \>1.50D, hyperopia \> 3.5D, Astigmatism \>1.50D, myopia more than 3D
Interventions
- DIAGNOSTIC_TEST objective pediatric vision screen "GCK glow fixation"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2020-03-03 |
What the finished NCT04297969 record still lists
NCT04297969 is an observational study that tracks outcomes without assigning an intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which objective pediatric vision screen "GCK glow fixation" is the first listed.
NCT04297969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04297969 about?
NCT04297969 is a clinical study titled "Hyperopia Detection GCK With Glow Fixation". "GoCheck Kids" has added to its iPhone 7+ smart phone with flash concentrator a non-accommodating glow box fixation target. In pediatric eye patients, the "GCK" with glow box is compared to cycloplegic refraction as well as School Bus Accommodation-relaxing skiascopy, "2WIN" photoscreener and "Retin...
What is the current status of trial NCT04297969?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2019-10-14. Estimated completion is 2020-03-03.
What interventions are being tested in trial NCT04297969?
The interventions under investigation include: objective pediatric vision screen "GCK glow fixation" (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04297969?
This trial is sponsored by Alaska Blind Child Discovery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI